GlaxoSmithKline (GSK)

Add to Watchlists
Create an Alert
42.26 +0.12  +0.28% NYSE Jul 2, 8:00PM Delayed 2m USD

GlaxoSmithKline PE Ratio (TTM):

6.550 for July 2, 2015

View 4,000+ financial data types

View Full Chart

GlaxoSmithKline PE Ratio (TTM) Chart

Export Data
Save Image

GlaxoSmithKline Historical PE Ratio (TTM) Data

View and export this data going back to 1976. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
July 2, 2015 6.550
July 1, 2015 6.531
June 30, 2015 6.455
June 29, 2015 6.514
June 26, 2015 6.647
June 25, 2015 6.744
June 24, 2015 6.717
June 23, 2015 6.723
June 22, 2015 6.734
June 19, 2015 6.674
June 18, 2015 6.699
June 17, 2015 6.647
June 16, 2015 6.649
June 15, 2015 6.533
June 12, 2015 6.620
June 11, 2015 6.696
June 10, 2015 6.654
June 9, 2015 6.534
June 8, 2015 6.547
June 5, 2015 6.596
June 4, 2015 6.685
June 3, 2015 6.824
June 2, 2015 6.857
June 1, 2015 6.843
May 29, 2015 6.877
   
May 28, 2015 6.942
May 27, 2015 6.914
May 26, 2015 6.795
May 22, 2015 7.015
May 21, 2015 7.061
May 20, 2015 6.956
May 19, 2015 6.925
May 18, 2015 6.922
May 15, 2015 6.939
May 14, 2015 6.973
May 13, 2015 6.902
May 12, 2015 7.016
May 11, 2015 7.086
May 8, 2015 7.018
May 7, 2015 6.854
May 6, 2015 7.132
May 5, 2015 7.067
May 4, 2015 7.182
May 1, 2015 7.125
April 30, 2015 7.153
April 29, 2015 7.252
April 28, 2015 7.289
April 27, 2015 7.261
April 24, 2015 7.221
April 23, 2015 7.178

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Price to Earnings Ratio

The price to earnings ratio (PE Ratio) is the measure of the share price relative to the annual net income earned by the firm per share. PE ratio shows current investor demand for a company share. A high PE ratio generally indicates increased demand because investors anticipate earnings growth in the future. The PE ratio has units of years, which can be interpreted as the number of years of earnings to pay back purchase price.

PE ratio is often referred to as the "multiple" because it demonstrates how much an investor is willing to pay for one dollar of earnings. PE Ratios are sometimes calculated using estimations of next year's earnings per share in the denominator. When this happens, it is usually noted.

For more information on evaluating valuation multiples similar to this, please see our original white paper research : Making Sense Of Valuation Multiples.
Learn More

Advertisement

GSK PE Ratio (TTM) Benchmarks

Companies
AstraZeneca 64.40
Bristol-Myers Squibb 50.07
Johnson & Johnson 17.62

GSK PE Ratio (TTM) Range, Past 5 Years

Minimum 6.455 Jun 30 2015
Maximum 40.47 Jan 04 2011
Average 18.84

GSK PE Ratio (TTM) Excel Add-In Codes

  • Metric Code: pe_ratio
  • Latest data point: =YCP("GSK", "pe_ratio")
  • Last 5 data points: =YCS("GSK", "pe_ratio", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.